Chuan Yin Selected Research

Therapeutics

1/2024	Metal Nanoparticles: Advanced and Promising Technology in Diabetic Wound Therapy.
12/2023	Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment.
1/2023	Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery.
1/2018	Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
10/2016	Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
11/2015	CD20 Antibody-Conjugated Immunoliposomes for Targeted Chemotherapy of Melanoma Cancer Initiating Cells.
6/2014	Hepatocellular Carcinoma: Basic and Transitional Research.
12/2011	Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
11/2008	Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuan Yin Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 11/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2008
5	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2014
4	Fibrosis (Cirrhosis) 01/2017 - 12/2008
3	Inflammation (Inflammations) 01/2022 - 11/2014
2	Wounds and Injuries (Trauma) 01/2024 - 07/2018
2	Carcinogenesis 08/2022 - 11/2008
2	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2013 - 12/2008
1	Bacterial Infections (Bacterial Infection) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2023
1	Diabetes Mellitus 02/2023
1	Stroke (Strokes) 02/2023
1	Hypertension (High Blood Pressure) 02/2023
1	Liver Diseases (Liver Disease) 10/2022
1	Diarrhea 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022
1	Hepatic Encephalopathy 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	AIDS-Related Complex (ARC) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2016
1	Necrosis 12/2016
1	Melanoma (Melanoma, Malignant) 11/2015
1	Carcinoma (Carcinomatosis) 10/2010

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 01/2018 - 11/2015
4	Hepatocyte Nuclear FactorsIBA 01/2018 - 06/2013
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2014
3	salinomycinIBA 01/2019 - 10/2016
3	Transcription Factors (Transcription Factor)IBA 12/2011 - 11/2008
2	RNA (Ribonucleic Acid)IBA 02/2024 - 08/2022
2	alpha-Tocopherol FDA Link 01/2019 - 01/2018
2	poly(lactide) (polylactic acid)IBA 01/2019 - 01/2018
2	Succinic Acid (Succinate)IBA 01/2019 - 01/2018
2	polyethylene glycol 1000IBA 01/2019 - 01/2018
2	Thioacetamide (Thioacetamid)IBA 07/2018 - 06/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2018
2	CeramidesIBA 05/2017 - 01/2015
2	Liposomes (Liposome)IBA 12/2016 - 11/2015
2	NF-kappa B (NF-kB)IBA 11/2014 - 12/2013
2	MicroRNAs (MicroRNA)IBA 12/2013 - 12/2013
1	methionine sulfoxide reductaseIBA 02/2024
1	SolutionsIBA 01/2024
1	Biocompatible Materials (Biomaterials)IBA 01/2024
1	ChitosanIBA 01/2024
1	AntioxidantsIBA 01/2024
1	HydrogelsIBA 01/2024
1	Urea (Carbamide)FDA LinkGeneric 02/2023
1	NitrogenIBA 02/2023
1	CytokinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 08/2022
1	6-methyladenineIBA 08/2022
1	immune RNA (I-RNA)IBA 08/2022
1	EnzymesIBA 08/2022
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	Rifaximin (L 105)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2019
1	dendrotoxin AIBA 01/2019
1	tocophersolanIBA 01/2019
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 07/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Fetal Proteins (Fetoprotein)IBA 01/2018
1	Polyglactin 910IBA 01/2018
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2018
1	VanadiumIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	tau Proteins (tau Protein)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	ElacridarIBA 01/2018
1	titanium alloy (TiAl6V4)IBA 01/2018
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Drug CarriersIBA 05/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Cathepsin BIBA 12/2016
1	MAP Kinase Kinase Kinase 5IBA 05/2016
1	Death Domain ReceptorsIBA 05/2016
1	AntibodiesIBA 11/2015
1	Vincristine (Oncovin)FDA LinkGeneric 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 12/2013
1	Hepatocyte Nuclear Factor 4IBA 10/2010
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 11/2009
1	Mitogen-Activated Protein Kinase 3IBA 11/2009
1	Small Interfering RNA (siRNA)IBA 11/2009
1	Mitogen-Activated Protein KinasesIBA 11/2009
1	Plasminogen Activator Inhibitor 1IBA 12/2008
1	CollagenIBA 12/2008

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2008
4	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
2	Immunotherapy 02/2024 - 01/2023
1	Ligation 11/2009
1	Injections 12/2008